The use of anticoagulants in the management of atrial fibrillation among general practices in England
about
The Mechanism of and Preventive Therapy for Stroke in Patients with Atrial FibrillationIs self-monitoring an effective option for people receiving long-term vitamin K antagonist therapy? A systematic review and economic evaluationUntreated atrial fibrillation in the United Kingdom: Understanding the barriers and treatment optionsEpidemiology of atrial fibrillation: European perspectiveClinical Features and Prognosis in Patients with Atrial Fibrillation and Prior Stroke: Comparing the Fushimi and Darlington AF Registries.Anticoagulant treatment in German family practices - screening results from a cluster randomized controlled trial.Automated Risk Assessment for Stroke in Atrial Fibrillation (AURAS-AF)--an automated software system to promote anticoagulation and reduce stroke risk: study protocol for a cluster randomised controlled trialOptimising stroke prevention in patients with atrial fibrillation: application of the GRASP-AF audit tool in a UK general practice cohort.Direct oral anticoagulants: key considerations for use to prevent stroke in patients with nonvalvular atrial fibrillation.Association between atrial fibrillation, anticoagulation, risk of cerebrovascular events and multimorbidity in general practice: a registry-based studyThe role of contraindications in prescribing anticoagulants to patients with atrial fibrillation: a cross-sectional analysis of primary care data in the UK.Screening for Atrial Fibrillation using Economical and accurate TechnologY (SAFETY)-a pilot study.Recent time trends in incidence, outcome and premorbid treatment of atrial fibrillation-related stroke and other embolic vascular events: a population-based study.Improving anticoagulation in atrial fibrillation: observational study in three primary care trusts.Prevalence and management of atrial fibrillation in primary care: a case study.Rivaroxaban and stroke prevention in patients with atrial fibrillation: new evidence.Non-vitamin K antagonist oral anticoagulants: impact of non-adherence and discontinuation.Underuse of anticoagulation in patients with atrial fibrillation.Suboptimal Use of Oral Anticoagulants in Atrial Fibrillation: Has the Introduction of Direct Oral Anticoagulants Improved Prescribing Practices?Demographics, treatment and outcomes of atrial fibrillation in a developing country: the population-based TuRkish Atrial Fibrillation (TRAF) cohort.Optimizing the use of oral anticoagulant therapy for atrial fibrilation in primary care: a pharmacist-led intervention.Impact of age on long-term anticoagulation and how gender and monitoring setting affect it: implications for decision making and patient managementStroke and death in elderly patients with atrial fibrillation in Japan compared with the United Kingdom.The Utilization of Antithrombotic Therapy in Older Australians With Atrial Fibrillation.Patients' and physicians' experiences of atrial fibrillation consultations and anticoagulation decision-making: A multi-perspective IPA design.Can we trust studies using audit software? A case study of atrial fibrillation audit.Warfarin Treatment and All-Cause Mortality in Community-Dwelling Older Adults with Atrial Fibrillation: A Retrospective Observational Study.Impact of advanced age on management and prognosis in atrial fibrillation: insights from a population-based study in general practice.Results from the Registry of Atrial Fibrillation (AFABE): Gap between Undiagnosed and Registered Atrial Fibrillation in Adults--Ineffectiveness of Oral Anticoagulation Treatment with VKA.Evolving landscape of stroke prevention in atrial fibrillation within the UK between 2012 and 2016: a cross-sectional analysis study using CPRD.Factors Influencing Oral Anticoagulant Prescribing Practices for Atrial Fibrillation.Sex differences in stroke prevention in atrial fibrillation in French primary care. Results of the AFIGP (Atrial Fibrillation In General Practice) database.Real life anticoagulation treatment of patients with atrial fibrillation in Germany: extent and causes of anticoagulant under-use.Temporal trends in antithrombotic treatment of real-world UK patients with newly diagnosed atrial fibrillation: findings from the GARFIELD-AF registry.How prepared are pharmacists to support atrial fibrillation patients in adhering to newly prescribed oral anticoagulants?Assessing appropriateness of drug therapy in older persons: Development and application of a medication assessment tool for long-term management of atrial fibrillation.Gender differences in stroke prevention in atrial fibrillation in general practice: using the GRASP-AF audit tool.Selection of Warfarin or One of the New Oral Antithrombotic Agents for Long-Term Prevention of Stroke among Persons with Atrial Fibrillation.Provider Specialty, Anticoagulation Prescription Patterns, and Stroke Risk in Atrial Fibrillation.Risk of stroke and transient ischaemic attack in patients with a diagnosis of resolved atrial fibrillation: retrospective cohort studies.
P2860
Q26747263-C221F961-F3AC-447E-A269-788C4F75E1BFQ28081070-6B283CBB-3D4A-4E97-98EE-281DE91018A9Q28081837-219BC1D9-6598-4F13-990E-F08ED7D303F9Q28315439-6C8A6B75-A6D3-473F-B97B-A3C6E42A12AAQ33603579-A384A2C2-81F9-4A5F-AA9F-63E630036BEBQ34422908-B294373B-62F1-4140-BAA9-B754F4543535Q34478966-32A7A5BB-42C2-4FCE-B3DF-42727F6B2B5CQ34769114-B2F09E62-3A4A-4F57-8170-49E16DA87F7CQ35746798-3350DC3D-1116-4FB5-9614-6FCE23B29016Q35972161-770828E3-3458-4B51-9161-A6073C30470FQ36409803-096EBD02-761A-47D4-8E37-09891114943FQ37598320-3A8E62B3-DA7F-47B2-950E-CD250765A20FQ37599572-B764C82A-6D15-46EC-80B2-0B3C739F81B4Q37725772-9E690AFD-E934-4D77-8AA8-A004C0853F53Q38180828-2D65531C-3BBF-45E2-8902-C795A1409A61Q38221812-EB12E51B-ECE6-4DF9-B118-AD4A82915462Q38662571-1045FFE4-17C3-498E-8093-F3DCDD74A18BQ38668964-D0808E4F-C4A9-4681-B4CC-91DB2C45DE8DQ38728028-DA9665EE-716B-4716-8F01-49A16F944EADQ38967685-27C5BE97-E7FC-4CBC-AB60-9B187E309CCAQ39066781-AB6831D1-257A-497F-8E35-472F44134494Q39675447-66B6BC28-3F83-433C-8A89-970446D86BA6Q39677398-0AB8FC01-DE69-4FB1-9C68-86D95DBFA955Q39905570-7D9017F1-1A36-45C0-8F3B-197E326BA2A0Q40352527-27208D81-E1BC-4074-BB89-88B9325BBC27Q40394144-A5A78182-0A93-4F3C-A35B-361EF41F6FF8Q40704670-39014B5C-3736-4179-B2CB-41817B59C443Q41663686-7B2C8F43-2EB1-42D1-AE7A-D53AF6623F51Q41808456-EFC6D178-9104-461C-A4EC-F1B46E2EABA6Q41902756-E5B4A9A9-E7DA-4751-8EFA-D22818613AB4Q42210118-819A3793-6A63-47FA-8A3D-D076C5BF65B0Q44061441-220C0F1C-139E-4179-A5C8-CF6F238CC1C0Q45005687-EE9BC3E0-0794-4F3D-B6D2-25E99795EB41Q47553794-0EDC681B-5EA3-4A12-A596-B26C0311D189Q48030210-1412B875-39DE-4088-B19D-50B0C4C7CB38Q48275867-4357AAD0-7781-49F2-AE36-C91B1B7C4B48Q51047250-3AA11ABF-F131-4CEB-87CB-BC6B3535CDAEQ53076603-6FDFE2AD-FC1B-468C-82E6-B7866293D13EQ54982283-D8A8B0AB-0A9C-4664-97CC-E29F6AB35A75Q55090406-1483669B-E5FC-468C-8717-19DDE8FF72C3
P2860
The use of anticoagulants in the management of atrial fibrillation among general practices in England
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 February 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The use of anticoagulants in t ...... g general practices in England
@en
The use of anticoagulants in t ...... general practices in England.
@nl
type
label
The use of anticoagulants in t ...... g general practices in England
@en
The use of anticoagulants in t ...... general practices in England.
@nl
prefLabel
The use of anticoagulants in t ...... g general practices in England
@en
The use of anticoagulants in t ...... general practices in England.
@nl
P2093
P2860
P1433
P1476
The use of anticoagulants in t ...... g general practices in England
@en
P2093
Campbell Cowan
Ian Robson
James Barrett
Keith Tyndall
Matthew Fay
Richard Healicon
W Robert Long
P2860
P304
P356
10.1136/HEARTJNL-2012-303472
P407
P577
2013-02-07T00:00:00Z